Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,38648,1569,1.06 [0.99-1.14],0.0760489059966246
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,38036,370,1.13 [0.98-1.29],0.0967525755509311
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,42170,292,1.13 [0.96-1.31],0.1348482564027862
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,29140,1316,1.11 [1.03-1.20],0.0092534491655943
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,42073,195,1.00 [0.83-1.21],0.987616214216184
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,39426,147,1.02 [0.82-1.27],0.8736026393863123
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",44180,193,1.02 [0.84-1.23],0.8751557221467264
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,44183,129,0.93 [0.74-1.18],0.5745042785674024
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,38526,99,1.35 [1.04-1.75],0.0237067095830493
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,42806,204,1.04 [0.86-1.25],0.6817662124165322
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Other septicaemia,42733,131,0.95 [0.75-1.20],0.6456466236403896
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,44314,120,1.21 [0.95-1.54],0.1143302849293812
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Other viral diseases,44321,148,1.06 [0.86-1.32],0.5846481158126416
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",44310,137,1.06 [0.85-1.33],0.5902555534509725
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Mycoses,43732,93,1.14 [0.87-1.50],0.3444080618082589
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",42262,710,1.06 [0.96-1.17],0.247934398603178
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,41799,247,1.19 [1.01-1.40],0.0433527914022795
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,42040,488,1.03 [0.91-1.16],0.6554328981090887
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",35529,110,0.88 [0.68-1.14],0.333922881660747
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",35515,96,0.89 [0.68-1.17],0.4032804007772322
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",35871,452,1.01 [0.89-1.14],0.9165277827435472
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",35884,465,1.01 [0.89-1.14],0.8846645870286522
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",20109,578,1.00 [0.89-1.11],0.9515402104791328
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",16083,195,0.92 [0.76-1.13],0.43146731384632
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",35512,93,1.06 [0.81-1.40],0.66619678015659
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,39687,1342,1.13 [1.05-1.22],0.000748221140627
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",42118,584,1.06 [0.95-1.19],0.2883841313302755
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,43507,210,0.95 [0.79-1.14],0.5642652524926193
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",44461,195,1.02 [0.85-1.24],0.8062707823893243
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm: Rectum,43972,124,1.14 [0.90-1.44],0.2825099320360693
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,44463,115,0.94 [0.73-1.21],0.6485330546079678
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm: Stomach,44550,84,0.83 [0.62-1.12],0.2261122456061988
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign lipomatous neoplasm,44077,513,0.87 [0.77-0.98],0.0234366281504238
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,44475,197,0.84 [0.69-1.01],0.0678639824208073
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,44482,154,0.79 [0.63-0.98],0.0343025653097959
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",44377,96,0.80 [0.60-1.05],0.1084919540347488
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Haemangioma, any site",44382,95,0.81 [0.62-1.07],0.1443597834086449
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Melanocytic naevi,44230,339,1.07 [0.93-1.23],0.3630091530060237
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,44497,153,1.26 [1.02-1.55],0.0343700322529546
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Other benign neoplasms of skin,44302,310,0.98 [0.84-1.14],0.7689498898453047
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm of breast,24017,120,0.91 [0.72-1.17],0.4685722606441989
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Leiomyoma of uterus,23583,871,0.99 [0.90-1.09],0.8294795243915463
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,42365,330,1.14 [0.98-1.32],0.0807434918205327
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,41823,591,1.18 [1.06-1.32],0.0029470905426156
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,41823,591,1.18 [1.06-1.32],0.0029470905426156
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),38582,768,1.10 [1.00-1.22],0.0475900379970459
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,43594,122,0.82 [0.64-1.04],0.104808217104908
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,44044,137,1.07 [0.86-1.34],0.5462690795392908
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,36060,1968,1.09 [1.02-1.16],0.0082426859756149
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,41984,917,1.07 [0.98-1.17],0.141228467692451
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,40533,205,0.95 [0.79-1.15],0.6198343030559021
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Peripheral artery disease,42519,190,1.00 [0.82-1.22],0.9791041814481466
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,40513,185,0.96 [0.79-1.17],0.6740912975253636
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,41253,925,1.15 [1.05-1.25],0.0036361627076897
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,41227,899,1.14 [1.04-1.25],0.0051274606613679
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,41272,304,0.92 [0.78-1.09],0.3257500835691417
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",41275,301,0.92 [0.78-1.10],0.3650883158158323
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,35762,1670,1.06 [0.98-1.13],0.1273706194922297
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",34306,214,1.00 [0.83-1.21],0.9993075673632986
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,35637,1545,1.06 [0.99-1.14],0.10440712500614
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,34179,87,1.40 [1.06-1.85],0.0186323974499411
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",34233,141,1.26 [1.01-1.58],0.0393346172100682
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,Any mental disorder,37756,1128,1.06 [0.98-1.15],0.1559579126797926
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",37037,409,1.02 [0.89-1.17],0.795348721843379
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",43863,299,0.97 [0.83-1.13],0.7056770538610891
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",43967,218,1.05 [0.87-1.25],0.6311006809309806
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,41480,104,0.84 [0.64-1.09],0.1884232625733949
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",44389,104,0.83 [0.64-1.07],0.1521483812914161
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",36732,104,0.83 [0.64-1.09],0.1749166633009624
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,Alcohol dependence,41503,127,0.91 [0.72-1.16],0.4637021994054243
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,Smoking dependency,41402,110,1.21 [0.94-1.57],0.1370697775365623
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",36727,99,0.98 [0.75-1.28],0.9033325072135432
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",37174,546,1.08 [0.96-1.21],0.2126359547831059
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,Depression,41805,479,1.06 [0.93-1.19],0.3802485824185024
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,Depression or dysthymia,36770,418,1.09 [0.96-1.25],0.1825914335873515
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",36847,219,1.12 [0.94-1.34],0.1994995993652608
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,Other anxiety disorders,42030,112,0.97 [0.75-1.25],0.7959937981369917
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Neurological diseases,38335,2566,1.06 [1.00-1.11],0.0526340643543382
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,34828,246,1.03 [0.87-1.22],0.7384113453512717
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,44285,196,1.01 [0.84-1.22],0.8854170370177386
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,42272,820,1.05 [0.95-1.15],0.3215006529361738
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Epilepsy,41707,255,0.86 [0.73-1.02],0.0854602486942202
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Migraine,41588,136,1.11 [0.88-1.39],0.3856276435483271
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",44031,122,1.11 [0.87-1.41],0.3919220227656405
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Transient ischemic attack,43137,136,1.10 [0.87-1.38],0.4267643547828884
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Other sleep disorders,41736,284,1.17 [1.00-1.37],0.0531041852879518
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Sleep apnoea,43569,217,1.15 [0.96-1.37],0.1363081161704137
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",42538,1155,1.05 [0.97-1.14],0.2155797413857997
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",41596,213,1.15 [0.96-1.37],0.1362208161213419
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,42046,663,1.03 [0.93-1.14],0.5955030038742206
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,44053,145,1.03 [0.83-1.29],0.7706879407585341
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Hemiplegia,44010,102,0.93 [0.71-1.22],0.6057988740652867
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Other neurological diseases,43707,206,0.94 [0.78-1.13],0.4841575348157964
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",43403,640,1.03 [0.93-1.15],0.5667697020303566
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,43130,367,1.10 [0.96-1.27],0.1787457811021012
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,42897,134,0.83 [0.66-1.05],0.1274562323392487
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,42965,202,1.10 [0.91-1.33],0.3128532341509245
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,42893,130,1.18 [0.93-1.48],0.1714876732072393
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,38370,272,1.05 [0.89-1.24],0.5599875210216381
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,38790,692,1.02 [0.92-1.14],0.6632283832427741
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,42809,349,1.11 [0.96-1.28],0.1541959860904325
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,43975,69,1.31 [0.96-1.80],0.0872685504448051
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,3774,69,1.21 [0.88-1.68],0.2453423783573575
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",40270,69,1.33 [0.98-1.82],0.07047584690945
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,43378,162,1.05 [0.85-1.29],0.6558512367112603
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,43301,85,1.17 [0.88-1.55],0.2927723390649959
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",43346,144,0.85 [0.68-1.06],0.1436407111881788
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,43607,171,0.84 [0.68-1.03],0.0909781946342339
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,44355,230,1.04 [0.88-1.24],0.6394889175339531
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,43080,184,1.03 [0.85-1.25],0.7773846389291007
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,31466,5556,1.02 [0.98-1.07],0.3290873202245415
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,43477,122,0.85 [0.66-1.08],0.1833282872549345
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Hypertension, essential",33183,3814,1.07 [1.01-1.12],0.0112799885873919
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Hypertension,33226,3857,1.07 [1.02-1.12],0.0105237014685813
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,29466,97,1.22 [0.93-1.59],0.1520434393542576
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",40760,2014,0.98 [0.92-1.05],0.5575841612454042
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Angina pectoris,39945,1199,0.95 [0.88-1.03],0.2522516805360191
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,42743,390,1.01 [0.88-1.15],0.9320893552764268
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,43141,788,0.98 [0.89-1.08],0.7065119193790101
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",44313,163,0.86 [0.69-1.06],0.1534128222632736
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",39242,496,0.96 [0.84-1.08],0.4756120438599799
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,40306,1592,0.98 [0.91-1.05],0.5778859919061934
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Pulmonary embolism,43103,191,0.98 [0.80-1.19],0.8038699848793869
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Venous thromboembolism,43313,399,1.00 [0.87-1.14],0.9588372369515804
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Secondary right heart disease,43081,169,0.87 [0.71-1.08],0.2015480286652674
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,43083,171,0.88 [0.72-1.09],0.2363784854385386
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",29531,162,0.88 [0.71-1.10],0.2610875050891064
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Cardiomyopathy,37038,104,1.19 [0.91-1.54],0.1972616970126386
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Conduction disorders,37141,207,0.96 [0.80-1.16],0.7004603327537792
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,24603,198,0.96 [0.79-1.16],0.6746325608612038
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,25160,755,0.91 [0.82-1.01],0.0879741430193501
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other arrhythmias,37049,115,1.06 [0.83-1.36],0.641766072063786
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,37098,164,0.75 [0.60-0.93],0.0077057159919396
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Heart failure, strict",42726,359,1.12 [0.97-1.29],0.1156305190098996
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",42997,260,1.05 [0.89-1.24],0.552627771242195
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",43056,218,1.11 [0.93-1.33],0.2557763073296216
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",43190,189,1.14 [0.94-1.38],0.1969884069218401
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,42510,128,0.90 [0.71-1.14],0.3697666151503409
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,42602,220,1.02 [0.85-1.22],0.8377896133292195
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),42005,245,1.07 [0.90-1.26],0.4705883214552316
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,DVT of lower extremities,41966,206,1.06 [0.88-1.27],0.5693287898291595
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",44166,198,1.10 [0.91-1.33],0.3191997537329966
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Varicose veins,42590,830,0.91 [0.82-0.99],0.0380987892097581
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Hypotension,42539,145,1.02 [0.81-1.27],0.8730976675903829
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,35574,3593,1.10 [1.05-1.15],5.641628631274744e-05
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,44221,191,1.10 [0.91-1.33],0.3230636602909518
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Influenza and pneumonia,41365,395,1.08 [0.94-1.23],0.2717196511162494
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",41316,346,1.06 [0.92-1.22],0.4247576615294385
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,42942,445,1.07 [0.95-1.22],0.2782403345918507
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,42936,439,1.07 [0.95-1.22],0.2661097969166289
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,43126,1057,1.07 [0.99-1.16],0.1068868988590044
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Chronic sinusitis,42239,170,1.03 [0.84-1.27],0.7599502747151281
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Nasal polyp,42282,213,1.17 [0.98-1.41],0.0824543935629356
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",42743,674,1.07 [0.97-1.19],0.1695124651215063
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Deviated nasal septum,42386,317,1.03 [0.89-1.20],0.6641600353259511
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,20517,109,1.17 [0.91-1.52],0.228176319621926
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,39752,1757,1.12 [1.05-1.19],0.0006709237197982
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Early onset COPD,42511,305,1.21 [1.04-1.41],0.0136460247192574
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",42553,347,1.18 [1.02-1.37],0.021826342246729
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",42553,347,1.18 [1.02-1.37],0.021826342246729
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",41502,1442,1.09 [1.02-1.17],0.0165274057060778
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Asthma,31814,1442,1.10 [1.03-1.19],0.006496511864478
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",31355,1442,1.10 [1.03-1.18],0.0075694400569653
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",31792,1420,1.10 [1.02-1.18],0.0092494385111371
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,43882,175,1.09 [0.89-1.34],0.3830829712110889
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Interstitial lung disease,41914,135,1.06 [0.84-1.34],0.6089159124667904
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",44018,135,1.06 [0.84-1.34],0.6175799508622323
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,41902,123,1.01 [0.80-1.29],0.913254250206951
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Pleural effusion,40963,192,1.01 [0.83-1.22],0.9564896915688912
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Other diseases of pleura,41190,419,1.10 [0.97-1.26],0.1441793301645597
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,42359,195,1.19 [0.99-1.44],0.0658936948256305
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,30369,10064,1.02 [0.99-1.06],0.1611751257024946
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",43636,736,1.06 [0.96-1.17],0.2380949744485097
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,44493,153,1.03 [0.83-1.27],0.7739108309218599
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Impacted teeth,44499,141,1.04 [0.84-1.30],0.6989970669381733
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Dental caries,43095,195,1.17 [0.97-1.41],0.1047247647280957
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,43080,180,1.11 [0.91-1.35],0.2955334838847661
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,44476,171,1.07 [0.87-1.30],0.5361515148064627
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,43068,168,1.03 [0.84-1.26],0.7735421639946914
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,42608,138,0.89 [0.71-1.13],0.3423644402787036
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,44343,95,0.85 [0.64-1.12],0.2411857360225398
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,33936,468,1.03 [0.91-1.16],0.6580868051689632
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",37201,3733,1.00 [0.95-1.04],0.8840493437050894
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Oesophagitis,34056,588,1.09 [0.97-1.21],0.1452995139967215
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,34693,1225,0.99 [0.92-1.07],0.8512100983851456
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,33603,135,1.01 [0.81-1.27],0.91277913097957
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,33837,369,1.04 [0.91-1.20],0.5668996122611659
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Oesophageal obstruction,33567,99,1.10 [0.84-1.43],0.5001496747149266
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Gastric ulcer,33722,254,0.98 [0.83-1.16],0.8459694234129311
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Duodenal ulcer,33692,224,1.10 [0.92-1.31],0.28807300882145
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",44317,159,1.09 [0.88-1.34],0.4278489541458535
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Chronic gastritis,33687,219,0.93 [0.78-1.12],0.4639661954306202
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),34865,1397,0.98 [0.91-1.05],0.5679528605456321
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diseases of appendix,44274,223,1.03 [0.87-1.23],0.7188680030371604
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Functional dyspepsia,34213,745,1.02 [0.92-1.12],0.736639550286169
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,33762,294,0.93 [0.80-1.09],0.3908448978739612
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,44254,280,0.90 [0.77-1.06],0.1939504455570919
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Acute appendicitis,44231,180,1.01 [0.83-1.23],0.9463897304514112
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Hernia,39050,2812,1.01 [0.96-1.07],0.6691290949558117
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Inguinal hernia,37276,1038,0.95 [0.87-1.04],0.244726773598908
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Umbilical hernia,36455,217,1.03 [0.86-1.24],0.7178419612404272
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Ventral hernia,36409,171,0.89 [0.73-1.10],0.2905584476345596
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,37733,1495,1.08 [1.01-1.16],0.0291396437667344
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,42871,1323,1.12 [1.04-1.21],0.0018381781878605
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of intestines,34938,3466,1.01 [0.97-1.06],0.5744183115145087
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",43963,107,1.17 [0.91-1.50],0.2317327374000117
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",44431,144,1.19 [0.96-1.48],0.1158478049445055
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Crohn disease,41692,144,1.20 [0.96-1.49],0.1039887752504809
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Crohn's disease NAS,41658,110,1.10 [0.86-1.41],0.4561289162990566
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",44308,237,1.04 [0.88-1.24],0.6496665734725319
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Ulcerative colitis,41785,237,1.05 [0.88-1.24],0.5993422467132594
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",41759,211,1.03 [0.86-1.23],0.7745511259483548
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,42625,1077,1.13 [1.04-1.23],0.0028451009795122
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,42613,1065,1.13 [1.04-1.22],0.0042008548183676
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,31647,175,1.13 [0.92-1.38],0.2351003889643496
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Intestinal stricture,43740,175,1.13 [0.92-1.38],0.2446952672226331
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",31589,117,1.20 [0.94-1.53],0.1451665524290685
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,32503,1031,1.04 [0.95-1.13],0.4321780317953102
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,31757,285,1.01 [0.86-1.18],0.9289117886831278
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,31965,493,1.17 [1.04-1.32],0.009030352550808
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Constipation,41785,445,1.16 [1.02-1.31],0.0216738465882377
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diseases of peritoneum,43765,156,1.01 [0.82-1.25],0.9261611879631516
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,31729,257,0.91 [0.77-1.08],0.2853053404543795
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,31601,129,0.91 [0.72-1.16],0.4541549906431495
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,33007,1535,1.00 [0.93-1.07],0.8890830239908568
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of intestine,31944,472,0.95 [0.84-1.08],0.4120211880863537
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,43741,132,0.98 [0.78-1.24],0.8977047690356335
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diseases of liver,43132,210,0.77 [0.64-0.93],0.00762563940378
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of liver,43038,116,0.80 [0.62-1.03],0.0782808088426714
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",42154,1054,1.05 [0.97-1.14],0.2255096785009412
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Cholelithiasis,41946,846,1.06 [0.96-1.16],0.2480618794957184
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Cholecystitis,41268,168,1.18 [0.96-1.44],0.1183716832050509
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,41180,80,1.23 [0.92-1.64],0.1694720904755244
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Acute pancreatitis,41209,109,0.87 [0.67-1.13],0.2907864235043514
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),44229,109,0.86 [0.66-1.11],0.2546161577149172
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diseases of the digestive system,42165,532,1.12 [1.00-1.26],0.0551145288987295
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Intestinal malabsorption,41750,117,1.22 [0.96-1.55],0.1077211379684833
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Coeliac disease,41731,98,1.21 [0.93-1.58],0.1518320508983784
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",41719,86,1.28 [0.97-1.70],0.0842350413406366
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,41972,339,1.09 [0.95-1.26],0.2332677436857902
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,GI-bleeding,41960,327,1.08 [0.93-1.25],0.2920583150237515
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,39103,2687,0.96 [0.91-1.02],0.1911353816120081
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,43761,187,0.96 [0.79-1.17],0.6677465616072953
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,43829,791,0.98 [0.89-1.07],0.6179706320602893
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,41808,989,0.98 [0.90-1.07],0.7088238163908042
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,42954,692,0.98 [0.89-1.09],0.7508409874825367
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",42414,152,0.86 [0.69-1.07],0.1787987992294151
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,42701,439,1.01 [0.89-1.15],0.9100349735892858
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,44051,155,0.90 [0.72-1.11],0.3288571195565545
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,44016,120,0.95 [0.74-1.21],0.6685000775488636
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,43990,94,0.94 [0.71-1.24],0.6638845458069529
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,43141,103,1.11 [0.86-1.44],0.419299290565161
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,43665,627,0.97 [0.87-1.08],0.5374587742713897
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,40976,157,0.87 [0.70-1.07],0.1911772896412847
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,40991,172,0.84 [0.69-1.04],0.107646271961974
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,40951,132,0.88 [0.70-1.11],0.2844692650477066
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",41195,376,1.03 [0.90-1.18],0.6705894426883268
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,41160,341,0.99 [0.85-1.14],0.864509298883337
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,32111,6921,1.05 [1.01-1.09],0.0157616595234734
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,34909,4027,1.06 [1.01-1.11],0.0163300146135979
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,40154,2108,1.09 [1.03-1.16],0.004719356798072
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,31141,259,1.18 [1.00-1.40],0.0454722939130927
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,31677,795,1.02 [0.93-1.13],0.6473424135612901
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",43808,248,1.19 [1.00-1.40],0.0464308909922911
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,43824,224,1.22 [1.03-1.46],0.0252986955933765
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,32868,1986,1.10 [1.03-1.17],0.0031823010825914
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",37335,1986,1.09 [1.03-1.17],0.0053374491727182
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,31004,122,0.91 [0.71-1.17],0.448519448953675
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",43574,118,0.86 [0.67-1.11],0.251983331321714
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,31255,373,0.92 [0.80-1.06],0.2317231843881667
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,31003,121,1.02 [0.80-1.31],0.8758019341856107
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,31380,498,1.11 [0.98-1.26],0.0868721628615181
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",44257,251,1.23 [1.04-1.45],0.0159367298779551
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,31796,914,1.13 [1.03-1.23],0.0106056645656924
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,31545,663,1.04 [0.93-1.16],0.4899822046281264
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,33126,2244,1.03 [0.97-1.09],0.3944938916042976
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),31002,120,1.11 [0.87-1.41],0.4048669951618003
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),31290,408,0.98 [0.86-1.12],0.7618524011719043
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,30975,93,0.93 [0.70-1.23],0.6101269818767345
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),30987,105,1.04 [0.80-1.36],0.75385534714453
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,31720,838,1.04 [0.95-1.14],0.4264470123479821
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,31606,724,1.05 [0.95-1.16],0.3752226076674246
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,34498,485,1.05 [0.93-1.18],0.4658466859358755
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,43549,247,1.00 [0.85-1.19],0.9848178452998956
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,43400,98,1.18 [0.90-1.54],0.224001458865335
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,38551,115,0.96 [0.75-1.23],0.7549956216298966
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,38960,524,0.96 [0.85-1.08],0.5145047898022184
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,40061,1625,1.00 [0.93-1.07],0.9933245268497984
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,38769,333,1.01 [0.87-1.17],0.9356094295936136
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,38587,151,0.91 [0.73-1.14],0.4268944057383456
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",39721,1285,1.02 [0.95-1.10],0.6117841596119633
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,38525,89,1.13 [0.86-1.50],0.3739151988456368
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,38853,417,1.06 [0.93-1.21],0.3577952788686548
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,38611,175,1.03 [0.84-1.25],0.7992163251077027
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,38570,134,1.01 [0.80-1.27],0.9382850219110644
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,38671,235,0.93 [0.78-1.11],0.4025793153788086
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,38549,113,1.11 [0.86-1.42],0.4320111977497034
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,38978,542,1.10 [0.98-1.23],0.1031946480374043
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,38586,540,1.06 [0.95-1.19],0.3083230524824981
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,38164,118,1.04 [0.82-1.33],0.7383496733367014
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,38200,154,0.89 [0.72-1.11],0.3076583088423601
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,38220,174,1.21 [0.99-1.47],0.0660009161604031
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",38133,87,1.21 [0.92-1.60],0.1797983838270536
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,38251,205,1.12 [0.93-1.35],0.2194944849334067
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],38229,183,1.03 [0.84-1.25],0.8040264633209588
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,38491,445,1.06 [0.93-1.20],0.371229570180836
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,38147,101,1.02 [0.78-1.33],0.892352484951951
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,38175,129,1.10 [0.87-1.40],0.4112260996840855
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,38255,209,1.06 [0.88-1.27],0.5596766631008363
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,38157,111,0.89 [0.69-1.15],0.363299111938054
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",38834,788,1.07 [0.97-1.18],0.1583641835472853
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,38345,299,1.02 [0.87-1.19],0.8138866009493835
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,38474,428,1.07 [0.94-1.22],0.2974043475697252
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,41273,300,0.93 [0.80-1.09],0.3709813572559236
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,41642,669,0.92 [0.82-1.02],0.1025505426956746
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,41055,82,0.91 [0.68-1.23],0.5480891094369822
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,41067,94,1.03 [0.78-1.36],0.8200095264464682
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,41145,172,0.92 [0.75-1.13],0.4449345299298132
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,35498,7332,1.00 [0.97-1.04],0.826270645550742
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,17657,1076,1.02 [0.94-1.11],0.6213599652790438
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,40242,377,1.11 [0.97-1.27],0.1396146952903733
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,39975,110,1.04 [0.81-1.35],0.7446408268642333
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Acute renal failure,40470,80,1.26 [0.94-1.69],0.1285204637830745
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,40475,85,1.41 [1.06-1.87],0.0171065330018773
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,40489,99,1.16 [0.89-1.51],0.2798821307330473
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Urolithiasis,43905,415,1.05 [0.92-1.20],0.4462743526707975
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,43812,112,1.29 [1.00-1.65],0.0463796897130627
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,43785,295,1.05 [0.90-1.22],0.5643862328016751
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,43637,147,1.09 [0.87-1.35],0.4570676986410948
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,40768,1805,1.01 [0.95-1.08],0.6898130505181324
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Cystitis,39118,155,0.91 [0.74-1.13],0.4080652191163496
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,39099,136,1.21 [0.97-1.52],0.0909885796033874
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,39422,459,1.04 [0.92-1.18],0.546441221484596
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Urethral stricture,39161,198,0.90 [0.75-1.10],0.3024625748063552
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,40150,1187,1.04 [0.96-1.13],0.317919935412837
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,17065,484,1.02 [0.89-1.15],0.8104799985877925
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),16668,87,0.98 [0.73-1.31],0.8984080177759733
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Hydrocele,16666,85,1.10 [0.83-1.47],0.512880638076944
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",16716,135,1.01 [0.81-1.28],0.8998027744204571
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,16719,138,1.20 [0.96-1.51],0.1090458007019507
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,16756,175,0.93 [0.76-1.14],0.4737873875878911
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23799,423,0.92 [0.80-1.04],0.1897339074294854
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,23507,131,0.83 [0.66-1.06],0.1317414404499775
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,23519,143,1.00 [0.80-1.24],0.9751876689288678
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,23482,106,0.87 [0.67-1.12],0.2750494803943403
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23737,489,0.95 [0.84-1.07],0.4030069979406453
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,23365,117,0.83 [0.65-1.07],0.153888804019638
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,23464,216,0.99 [0.82-1.18],0.8975612419293837
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,21951,4020,1.00 [0.95-1.05],0.9960956234843632
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Endometriosis,18240,309,1.11 [0.95-1.29],0.1742957178120748
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,18018,87,1.34 [1.01-1.77],0.0433600241190102
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),18073,142,1.06 [0.85-1.32],0.6137659550687928
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18631,700,1.08 [0.97-1.20],0.1448362942774613
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,18284,353,0.93 [0.81-1.08],0.3344849710120073
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18766,835,0.97 [0.88-1.06],0.4891464891277944
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Uterine polyps,18202,271,0.83 [0.71-0.98],0.0288880182897309
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",18316,385,1.04 [0.90-1.19],0.6094467244794985
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,18019,88,1.24 [0.94-1.64],0.1251896799271664
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,18100,169,1.16 [0.95-1.43],0.1444870975563184
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",24032,232,1.16 [0.98-1.38],0.0842210129975098
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,24043,220,1.16 [0.97-1.38],0.1105041570105409
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,24064,118,1.20 [0.94-1.53],0.1365411131006131
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",24054,130,1.22 [0.97-1.53],0.0931618777923281
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,18061,130,0.91 [0.72-1.15],0.4311931722986003
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,18032,101,0.90 [0.69-1.17],0.416345103532614
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,18057,126,1.10 [0.87-1.40],0.4147786692033204
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Irregular menses,23976,411,1.19 [1.04-1.35],0.0101745105612582
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",19108,1177,1.06 [0.98-1.15],0.1650523094375527
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Menorrhagia,18696,765,1.01 [0.91-1.11],0.8881276432836783
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",24051,179,1.09 [0.90-1.33],0.3759761998612561
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,18340,409,0.89 [0.78-1.02],0.0876190232056718
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,18205,274,1.07 [0.91-1.26],0.4053291172756401
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18722,791,0.96 [0.87-1.06],0.4258428869354077
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Female infertility,18019,88,1.16 [0.87-1.55],0.310595538960043
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",18012,81,1.12 [0.83-1.52],0.4501317650043005
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,24061,735,1.01 [0.91-1.13],0.7995113276396222
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,24067,1011,1.07 [0.97-1.17],0.1952762424018024
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,24061,398,1.14 [0.99-1.31],0.063792772284694
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,23775,112,1.26 [0.98-1.62],0.0713931886561394
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,23823,160,1.03 [0.83-1.28],0.7582882772222199
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,23804,141,1.24 [0.99-1.55],0.0632973148724265
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",24077,144,1.00 [0.79-1.25],0.9663079006553508
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,24079,142,0.98 [0.78-1.23],0.8484889318459733
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,24076,367,0.92 [0.79-1.06],0.2399219291473597
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,23818,109,0.72 [0.55-0.94],0.0159587615190932
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,23914,205,0.94 [0.78-1.14],0.5472236536686091
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,23450,124,1.15 [0.90-1.47],0.2586504357108459
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,23496,170,0.97 [0.78-1.20],0.7704284565822138
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,23529,203,1.03 [0.85-1.25],0.7492742975042072
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,23451,125,0.97 [0.75-1.24],0.7886494665882073
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,23441,115,1.09 [0.84-1.40],0.5199318621296918
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,23453,127,0.84 [0.66-1.08],0.1800923928354743
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,23250,194,1.11 [0.91-1.35],0.2960702883521745
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],23434,378,1.00 [0.87-1.16],0.9549389875997292
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,23614,558,1.09 [0.97-1.24],0.1619968149286528
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",24081,148,1.09 [0.87-1.36],0.4509575815048453
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,22854,113,1.05 [0.81-1.35],0.7234344012659173
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",23141,85,0.91 [0.68-1.23],0.551005878046111
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,24087,289,0.95 [0.81-1.12],0.5513205371119645
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,24022,224,0.92 [0.77-1.11],0.4085085817498846
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",24076,213,1.10 [0.91-1.32],0.3325922356032819
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",24066,203,1.11 [0.91-1.34],0.3023760719421904
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",43875,103,0.79 [0.60-1.04],0.0924174037364242
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Falls/tendency to fall,40226,1017,0.95 [0.87-1.04],0.2525246944713527
